Interplay Between Serum Potassium Abnormalities and RAAS Inhibitor Discontinuation in Patients With Chronic Cardiovascular, Metabolic, and Renal Conditions
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
European Journal of Internal Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Serum potassium abnormalities, renin-angiotensin-aldosterone system inhibitor discontinuation, and clinical outcomes in patients with chronic cardiovascular, metabolic, and renal conditions: A population-based analysis
Eur. J. Intern. Med. 2024 Jul 01;125(xx)89-97, S Jiménez-Marrero, M Cainzos-Achirica, D Monterde, E Vela, C Enjuanes, S Yun, A Garay, P Moliner, M Corbella, S Jovells-Vaqué, L Alcoberro, A Pons-Riverola, R Ramos-Polo, H Morillas, JA Gómez-Hospital, J Comin-ColetFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.